Results 11 to 20 of about 167,693 (338)

Methylprednisolone in Pediatric Cardiac Surgery: Is There Enough Evidence?

open access: yesFrontiers in Cardiovascular Medicine, 2021
Corticosteroids have been used to decrease the inflammatory response to cardiac surgery and cardiopulmonary bypass in children for decades. Sparse information is present concerning the pharmacokinetics and pharmacodynamics of corticosteroids in the ...
Annewil van Saet   +5 more
doaj   +1 more source

Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia

open access: yesPLoS ONE, 2021
Background There is no effective therapy for the severe acute respiratory syndrome by coronavirus 2 (SARS-CoV2) responsible for the Coronavirus disease 2019 (Covid-19).
M. Pinzón   +10 more
semanticscholar   +1 more source

Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial

open access: yesEuropean Respiratory Journal, 2022
Rationale Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone in addition to standard treatment in COVID-19 pneumonia ...
C. Salvarani   +44 more
semanticscholar   +1 more source

Case report: Subacute combined degeneration of the spinal cord due to nitrous oxide abuse

open access: yesFrontiers in Neurology, 2023
BackgroundNitrous oxide (N2O) is an increasingly popular recreational drug. N2O irreversibly disturbs the metabolism of vitamin B12, resulting in a functional deficiency.
Huijuan Wu   +7 more
doaj   +1 more source

Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease

open access: yesJAMA ophthalmology, 2022
This meta-analysis conducts a matching-adjusted indirect comparison of teprotumumab vs intravenous methylprednisolone vs placebo in patients with moderate-to-severe thyroid eye disease.
Raymond S. Douglas   +7 more
semanticscholar   +1 more source

Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)

open access: yesEuropean Respiratory Journal, 2022
Background Dysregulated systemic inflammation is the primary driver of mortality in severe coronavirus disease 2019 (COVID-19) pneumonia. Current guidelines favour a 7–10-day course of any glucocorticoid equivalent to dexamethasone 6 mg daily.
F. Salton   +15 more
semanticscholar   +1 more source

Methylprednisolone for Heart Surgery in Infants - A Randomized, Controlled Trial.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Although perioperative prophylactic glucocorticoids have been used for decades, whether they improve outcomes in infants after heart surgery with cardiopulmonary bypass is unknown. METHODS We conducted a multicenter, prospective, randomized,
K. Hill   +30 more
semanticscholar   +1 more source

Methylprednisolone in adults hospitalized with COVID-19 pneumonia

open access: yesWiener Klinische Wochenschrift, 2021
To determine whether a 6-day course of methylprednisolone (MP) improves outcome in patients with severe SARS-CoV‑2 (Corona Virus Disease 2019 [COVID-19]).
L. Corral-Gudino   +16 more
semanticscholar   +1 more source

Effects of Methylprednisolone on Myocardial Function and Microcirculation in Post-resuscitation: A Rat Model

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundPrevious studies have demonstrated that inflammation and impaired microcirculation are key factors in post-resuscitation syndromes. Here, we investigated whether methylprednisolone (MP) could improve myocardial function and microcirculation by ...
Changsheng Wang   +17 more
doaj   +1 more source

Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Previous trials have suggested that vasopressin and methylprednisolone administered during in-hospital cardiac arrest might improve outcomes.
L. Andersen   +32 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy